107 related articles for article (PubMed ID: 25283341)
1. Dopaminergic activity and behaviour in SOCS2 transgenic mice: Revealing a potential drug target for schizophrenia.
Ratnayake U; Basrai HS; Turnley AM; van den Buuse M
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():247-53. PubMed ID: 25283341
[TBL] [Abstract][Full Text] [Related]
2. Altered N-methyl-D-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activity.
van den Buuse M; Halley P; Hill R; Labots M; Martin S
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jun; 37(2):237-46. PubMed ID: 22361156
[TBL] [Abstract][Full Text] [Related]
3. Decreased amphetamine-induced locomotion and improved latent inhibition in mice mutant for the M5 muscarinic receptor gene found in the human 15q schizophrenia region.
Wang H; Ng K; Hayes D; Gao X; Forster G; Blaha C; Yeomans J
Neuropsychopharmacology; 2004 Dec; 29(12):2126-39. PubMed ID: 15213703
[TBL] [Abstract][Full Text] [Related]
4. Rasgrf2 controls dopaminergic adaptations to alcohol in mice.
Easton AC; Rotter A; Lourdusamy A; Desrivières S; Fernández-Medarde A; Biermann T; Fernandes C; Santos E; Kornhuber J; Schumann G; Müller CP
Brain Res Bull; 2014 Oct; 109():143-50. PubMed ID: 25454123
[TBL] [Abstract][Full Text] [Related]
5. The dopamine transporter: a crucial component regulating dopamine transmission.
Jaber M; Jones S; Giros B; Caron MG
Mov Disord; 1997 Sep; 12(5):629-33. PubMed ID: 9380041
[TBL] [Abstract][Full Text] [Related]
6. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
[TBL] [Abstract][Full Text] [Related]
8. Enhanced effect of dopaminergic stimulation on prepulse inhibition in mice deficient in the alpha subunit of G(z).
van den Buuse M; Martin S; Brosda J; Leck KJ; Matthaei KI; Hendry I
Psychopharmacology (Berl); 2005 Dec; 183(3):358-67. PubMed ID: 16220329
[TBL] [Abstract][Full Text] [Related]
9. Pdxdc1 modulates prepulse inhibition of acoustic startle in the mouse.
Feldcamp LA; Boutros PC; Raymond R; Fletcher PJ; Nobrega JN; Wong AHC
Transl Psychiatry; 2017 May; 7(5):e1125. PubMed ID: 28485732
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.
Mereu M; Contarini G; Buonaguro EF; Latte G; Managò F; Iasevoli F; de Bartolomeis A; Papaleo F
Neuropharmacology; 2017 Jul; 121():179-194. PubMed ID: 28454982
[TBL] [Abstract][Full Text] [Related]
11. Modafinil disrupts prepulse inhibition in mice: strain differences and involvement of dopaminergic and serotonergic activation.
Kwek P; van den Buuse M
Eur J Pharmacol; 2013 Jan; 699(1-3):132-40. PubMed ID: 23219987
[TBL] [Abstract][Full Text] [Related]
12. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
[TBL] [Abstract][Full Text] [Related]
13. Modafinil-induced conditioned place preference via dopaminergic system in mice.
Nguyen TL; Tian YH; You IJ; Lee SY; Jang CG
Synapse; 2011 Aug; 65(8):733-41. PubMed ID: 21157933
[TBL] [Abstract][Full Text] [Related]
14. Analysis of neuronal subpopulations in mice over-expressing suppressor of cytokine signaling-2.
Ransome MI; Turnley AM
Neuroscience; 2005; 132(3):673-87. PubMed ID: 15837129
[TBL] [Abstract][Full Text] [Related]
15. Chronic stress changes prepulse inhibition after amphetamine challenge: the role of the dopaminergic system.
Lehner MH; Karas-Ruszczyk K; Zakrzewska A; Gryz M; Wislowska-Stanek A; Kolosowska K; Chmielewska N; Skorzewska A; Turzynska D; Sobolewska A; Mierzejewski P; Plaznik A
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30342432
[TBL] [Abstract][Full Text] [Related]
16. The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review.
Dahoun T; Trossbach SV; Brandon NJ; Korth C; Howes OD
Transl Psychiatry; 2017 Jan; 7(1):e1015. PubMed ID: 28140405
[TBL] [Abstract][Full Text] [Related]
17. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice.
Vuillermot S; Feldon J; Meyer U
Exp Neurol; 2011 Nov; 232(1):22-32. PubMed ID: 21820432
[TBL] [Abstract][Full Text] [Related]
18. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.
Lähdesmäki J; Sallinen J; MacDonald E; Scheinin M
Neuropsychopharmacology; 2004 Jul; 29(7):1282-93. PubMed ID: 15039766
[TBL] [Abstract][Full Text] [Related]
19. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice.
Unger EL; Eve DJ; Perez XA; Reichenbach DK; Xu Y; Lee MK; Andrews AM
Neurobiol Dis; 2006 Feb; 21(2):431-43. PubMed ID: 16230020
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Nef expression in microglia disrupts dopaminergic and immune functions with associated mania-like behaviors.
Acharjee S; Branton WG; Vivithanaporn P; Maingat F; Paul AM; Dickie P; Baker GB; Power C
Brain Behav Immun; 2014 Aug; 40():74-84. PubMed ID: 24607605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
